AKANVSSYRE• 28 Days (Normalized)
AKAN vs SYRE (Akanda Corp. vs Spyre Therapeutics Inc.)
Showing Closing Date Range from Aug, 14 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
AKAN Performance $3.07
-52.4%
Akanda Corp.
Normalized Baseline0.00%
SYRE Performance $90.6
-12.57%
Spyre Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin SYRE LEADS
-39.83%
SYRE outperforming by 39.83%
AKANSYRE
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
AKAN SYRE
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | AKAN Price | AKAN Gain (%) | SYRE Price | SYRE Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $3.07 | -52.40% | $90.60 | -12.57% | -39.83% |
| Sep 10, 2026 | $3.00 | -53.49% | $88.71 | -14.40% | -39.09% |
| Sep 09, 2026 | $3.25 | -49.61% | $86.93 | -16.12% | -33.49% |
| Sep 08, 2026 | $3.28 | -49.15% | $90.79 | -12.39% | -36.76% |
| Sep 04, 2026 | $3.35 | -48.06% | $88.98 | -14.14% | -33.92% |
| Sep 03, 2026 | $3.67 | -43.10% | $87.25 | -15.81% | -27.29% |
| Sep 02, 2026 | $3.74 | -42.02% | $87.05 | -16.00% | -26.02% |
| Sep 01, 2026 | $3.70 | -42.64% | $88.50 | -14.60% | -28.04% |
| Aug 31, 2026 | $4.08 | -36.82% | $89.33 | -13.80% | -23.02% |
| Aug 28, 2026 | $3.89 | -39.69% | $90.36 | -12.81% | -26.88% |
| Aug 27, 2026 | $4.23 | -34.42% | $93.62 | -9.66% | -24.76% |
| Aug 26, 2026 | $4.24 | -34.26% | $93.61 | -9.67% | -24.59% |
| Aug 25, 2026 | $4.95 | -23.26% | $107.36 | +3.60% | -26.86% |
| Aug 24, 2026 | $3.71 | -42.56% | $106.65 | +2.91% | -45.47% |
| Aug 21, 2026 | $3.86 | -40.16% | $106.49 | +2.76% | -42.92% |
Page 1 of 2